EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

18 F‐PSMA‐1007 PET/CT Demonstrates Higher Accuracy for Biochemically Recurrent Prostate Cancer Compared to Contemporary Conventional Imaging

Zachary Stanton, Bonnie Woloschuk, Alexander Tamm, Ryan Hung iD, Adwait Trivedi, Michael Kolinsky, Nawaid Usmani, Lindsay Rowe, Ronald Moore, Frank Wuest, Jonathan Abele iD

Advances in Urology · 2026-01 · 2026 (1)

DOI: 10.1155/aiu/8550174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Urology, online erschienen am 05.07.2026. Verfasst von Zachary Stanton und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alberta Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The goal of this study was to compare the accuracy of 18 F‐PSMA‐1007 PET/CT to contemporary conventional imaging (contrast‐enhanced CT scan of the chest, abdomen, and pelvis and a 99m Tc‐MDP whole body bone scan with SPECT/CT of the torso) in the setting of biochemically recurrent prostate cancer.

Methods

This prospective nonrandomized Phase II cohort study clinical trial included 85 patients with biochemically recurrent prostate cancer (previous therapy). 18 F‐PSMA‐1007 whole body PET/CT imaging was performed in all patients, with conventional imaging (contrast‐enhanced CT scan of the chest, abdomen, and pelvis and a 99m Tc‐MDP whole body bone scan with SPECT/CT of the torso) then performed within 12 days. PROMISE criteria were used for PET/CT interpretation. After a minimum 1‐year follow‐up period, lesion‐level and patient‐level analyses were performed based on previously published reference criteria (Lawhn‐Heath et al. 2019). The accuracy data were compared. Referring physicians were surveyed to help determine if the scans altered treatment. Categorical variables were compared using the McNemar test ( p < 0.05 significant).

Results

53 patients with a total of 72 evaluable lesions were included in the analysis. 18 F‐PSMA‐1007 PET/CT had a higher sensitivity than conventional imaging on a lesion level (100% compared with 58.3%) and higher overall accuracy on a patient level (90.6% compared with 62.3%, p < 0.05). The referring physicians felt that the 18 F‐PSMA‐1007 PET/CT scans were beneficial to the clinical care of the patient in 90.6% of cases.

Conclusion

Overall, the findings support the use of 18 F‐PSMA‐1007 over conventional imaging in the evaluation of patients with biochemically recurrent prostate cancer. Trial Registration: ClinicalTrials.gov.identifier: NCT04733768

Schlagwörter

Stichwörter der Autor:innen

CTPET/CTPSMA-1007biochemical recurrencebone scanprostate cancer

Autor:innen und Institutionen

  • Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.
  • Department of Oncology, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.
  • Department of Surgery, University of Alberta, Edmonton, Alberta, Canada, ualberta.ca.

ORCID-Profile: Ryan Hung, Jonathan Abele

Förderung

  • Alberta Cancer Foundation

Zitieren

APA

Stanton, Z., Woloschuk, B., Tamm, A., Hung, R., Trivedi, A., Kolinsky, M., Usmani, N., Rowe, L., Moore, R., Wuest, F., & Abele, J. (2026). 18 F‐PSMA‐1007 PET/CT Demonstrates Higher Accuracy for Biochemically Recurrent Prostate Cancer Compared to Contemporary Conventional Imaging. Advances in Urology, 2026(1). https://doi.org/10.1155/aiu/8550174

Vancouver

Stanton Z, Woloschuk B, Tamm A, Hung R, Trivedi A, Kolinsky M, et al. 18 F‐PSMA‐1007 PET/CT Demonstrates Higher Accuracy for Biochemically Recurrent Prostate Cancer Compared to Contemporary Conventional Imaging. Advances in Urology. 2026;2026(1). doi:10.1155/aiu/8550174

BibTeX
@article{Stanton2026,
  author = {Stanton, Zachary and Woloschuk, Bonnie and Tamm, Alexander and Hung, Ryan and Trivedi, Adwait and Kolinsky, Michael and Usmani, Nawaid and Rowe, Lindsay and Moore, Ronald and Wuest, Frank and Abele, Jonathan},
  title = {18 F‐PSMA‐1007 PET/CT Demonstrates Higher Accuracy for Biochemically Recurrent Prostate Cancer Compared to Contemporary Conventional Imaging},
  journal = {Advances in Urology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/aiu/8550174}
}
Kostenlos starten →